11.6.3 Sympathomimetics

Brimonidine is a selective alpha 2 stimulant licensed for use in patients for whom beta-blockers are inappropriate or as adjunctive therapy when intra-ocular pressure is inadequately controlled by other antiglaucoma therapy.

Brimonidine carries an allergy risk of around 20% usually seen after 4-6 months of use.

Brimonidine
  • Eye drops 0.2% (£1.35 = 5ml)

Dose

  • Apply twice a day
Brimonidine/ Timolol
  • Eye drops brimonidine 0.2%, timolol 0.5% (£10.00 = 5ml)

Dose

  • Apply twice a day
Apraclonidine
  • Ophthalmic solution 0.5% 5ml

 

Home > Formulary > Chapters > 11. Eye > 11.6 Treatment of glaucoma > 11.6.3 Sympathomimetics

 

  • First line
  • Second line
  • Specialist
  • Hospital